Tag Archives: Eli Lilly

WPP’s Grey Group acquired full-service healthcare and consumer agency Entreprise de Communications Tank Inc.

LONDON, 22-Dec-2016 — /EuropaWire/ — WPP announces that its wholly-owned operating company Grey Group, the global marketing communications company, has acquired Entreprise de Communications Tank Inc. (“Tank”), a leading full-service healthcare and consumer agency in Canada. Tank’s audited net revenues were … Read the full press release

Helena Bragd bliver administrerende direktør for Becton Dickinson i Norden

OXFORD, 17-12-2015 — /EuropaWire/ — Helena Bragd tillsätts som vd för Becton, Dickinson and Companys (BD) affärsenhet BD Nordics. Helena har över 20 års erfarenhet som chef inom farmaceutisk och medicinteknisk verksamhet hos välkända aktörer inom branschen, bland annat ResMed, … Read the full press release

Helena Bragd joins Becton Dickinson to lead newly empowered Nordic business

OXFORD, 17-12-2015 — /EuropaWire/ — Helena Bragd has joined global medical technology leader Becton, Dickinson and Company (BD) as General Manager for the Nordic region. Helena brings more than 20 years of pharmaceutical- and med-tech leadership experience to the role, … Read the full press release

Boehringer Ingelheim, Eli Lilly announce positive top-line results from EMPA-REG OUTCOME

Ingelheim, Germany and Indianapolis, US, 24-8-2015 — /EuropaWire/ — Boehringer Ingelheim and Eli Lilly and Company today announced positive top-line results from EMPA-REG OUTCOME®. This is a long-term clinical trial investigating cardiovascular (CV) outcomes for Jardiance® (empagliflozin) in more than 7,000 … Read the full press release

AstraZeneca and Eli Lilly to enrol more than 1,500 patients in 15 countries to their Phase II/III study of oral beta secretase cleaving enzyme (BACE) inhibitor in development as potential treatment for Alzheimer’s disease

Phase II/III trial of AZD3293, an oral potent small molecule inhibitor of BACE, aims to enrol more than 1,500 patients in 15 countries LONDON, 2-12-2014 — /EuropaWire/ — AstraZeneca and Eli Lilly and Company (Lilly) today announced enrolment of the … Read the full press release

Sanofi filed patent infringement suit against Eli Lilly over Lantus® and Lantus® SoloStar®

Paris, France, 31-1-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it filed a patent infringement suit against Eli Lilly and Company ( “Lilly”) on January 30, 2014 in the United States District Court for the District of Delaware. In … Read the full press release

Boehringer Ingelheim, Lilly released results of new meta-analysis regarding CV events in linagliptin Phase 3 trials presented at the American Diabetes Association

Ingelheim, Germany and Indianapolis, US, 1-7-2013 — /europawire.eu/ — Boehringer Ingelheim and Eli Lilly and Company today announced results from a new analysis of Phase III data demonstrating that treatment with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is not associated with … Read the full press release